Showing results (191-200 of 499) with videos related to
Sort By:
Pageof 50
Antiviral Therapy|April 14, 2010
Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohortMartin Vogel, Stéphanie Dominguez, Sanjay Bhagani, et al.The Journal of Infectious Diseases|December 16, 2003
Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtideSharon Walmsley, Keith Henry, Christine Katlama, et al.AIDS (London, England)|November 6, 2003
Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGAMarc-Antoine Valantin, Camille Aubron-Olivier, Jade Ghosn, et al.AIDS (London, England)|April 2, 2005
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortDeborah Konopnicki, Amanda Mocroft, S de Wit, et al.Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.AIDS (London, England)|March 3, 2006
Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitorsBénédicte Roquebert, Isabelle Malet, Marc Wirden, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 21, 2013
Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-upRuxandra Calin, Marguerite Guiguet, Nathalie Desire, et al.The Journal of Antimicrobial Chemotherapy|January 25, 2020
Efficacy of intermittent short cycles of integrase inhibitor-based maintenance ART in virologically suppressed HIV patientsRuxandra Calin, Stephanie Landowski, Marc-Antoine Valantin, et al.The Journal of Antimicrobial Chemotherapy|September 27, 2023
Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in FranceMacha Tetart, Priscila Passecountrin, Anaïs Lesourd, et al.AIDS (London, England)|August 2, 2003
Virological rebound after suppression on highly active antiretroviral therapyAmanda Mocroft, Lidia Ruiz, Peter Reiss, et al.Pageof 50